You are here

580b57fcd9996e24bc43c53e   LinkedIn Logo 500x500   Facebook logo square   Iguana Trans cropped

event icon
Date
18.07.19 - 20.07.19
Palace Hotel Buxton, Palace Road, Buxton, SK17 6AG

A Biochemical Society Scientific Meeting


Overview

The PI 3-kinase (PI3K) pathway is an intracellular signalling pathway at the crossroads of cell signalling and vesicular traffic. The Biochemical Society last organised a meeting on this topic in 2006 and, since then, the PI3K field has massively expanded. After some challenging years in PI3K pathway drug development, good progress has recently been made, with three PI3K inhibitors now approved for oncology and several others in the registration pipeline.

This meeting focuses on the biology and signalling of the class I isoforms of PI3K, and the drugs that have been generated to interfere with their function in disease. We have invited speakers who bridge the gap between basic science and translation, as well as industry speakers to provide an update on their PI3K programmes and clincians who have been running clincial trials in this area.

Aim

  • Provide networking opportunities for the UK/EU PI3K community and beyond
  • Connect currently dispersed fields which have a common ground in PI3K
  • Provide an update on the latest discoveries in the PI3K field, with a focus on understanding the basic biology and signalling, the disease state and translational opportunities
  • Provide a networking opportunity for early career researchers

Contact

For further information and to book please visit the Biochemical Society website.

Continuing Professional Development (CPD)

This event is approved by the Royal Society of Biology for purposes of CPD and may be counted as 72 CPD credits.

We use cookies: to perform functions such as login and account management; and to track usage with Google analytics to improve our website. To find out more about the cookies we use and how to delete them, see our cookie policy.   I accept cookies from this site.